Most Frequent Solid Tumor Malignancies and Significant Variables
Tumor . | RR by Variable . | ||||||
---|---|---|---|---|---|---|---|
High-Dose TBI . | Limited Field Irradiation . | GVHD . | T-Cell Depletion . | HLA Nonidentity . | Male Gender . | ||
Acute (II-IV) . | Chronic . | ||||||
Squamous cell carcinoma | |||||||
Buccal cavity (n = 14) | 3.0 | 136* | 1.7 | 6* | 0 | 0 | 9.7* |
Skin (n = 8) | 0.2 | 0 | 2.1 | 22* | 0 | 0 | ∞* |
Thyroid CA (n = 7) | 5.8 | 0 | 1.9 | 0 | 4.9 | 0 | 0.4 |
Bone or connective tissue (n = 8) | 0.6 | 0 | 0.4 | 0.6 | 0 | 2.2 | 1.2 |
Brain or other CNS (n = 10) | 4.3 | 0 | 0.4 | 0 | 0 | 0.6 | 2.5 |
Melanoma, skin (n = 9) | 8.2 | 0 | 0.6 | 0.4 | 4.5 | 0 | 0.4 |
Tumor . | RR by Variable . | ||||||
---|---|---|---|---|---|---|---|
High-Dose TBI . | Limited Field Irradiation . | GVHD . | T-Cell Depletion . | HLA Nonidentity . | Male Gender . | ||
Acute (II-IV) . | Chronic . | ||||||
Squamous cell carcinoma | |||||||
Buccal cavity (n = 14) | 3.0 | 136* | 1.7 | 6* | 0 | 0 | 9.7* |
Skin (n = 8) | 0.2 | 0 | 2.1 | 22* | 0 | 0 | ∞* |
Thyroid CA (n = 7) | 5.8 | 0 | 1.9 | 0 | 4.9 | 0 | 0.4 |
Bone or connective tissue (n = 8) | 0.6 | 0 | 0.4 | 0.6 | 0 | 2.2 | 1.2 |
Brain or other CNS (n = 10) | 4.3 | 0 | 0.4 | 0 | 0 | 0.6 | 2.5 |
Melanoma, skin (n = 9) | 8.2 | 0 | 0.6 | 0.4 | 4.5 | 0 | 0.4 |
Data from Curtis et al.131
P < .01.